On Tuesday, Mirum Pharmaceuticals Inc (NASDAQ: MIRM) opened lower -4.91% from the last session, before settling in for the closing price of $50.89. Price fluctuations for MIRM have ranged from $33.45 to $54.23 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 4.14%. Company’s average yearly earnings per share was noted 39.83% at the time writing. With a float of $40.03 million, this company’s outstanding shares have now reached $49.45 million.
Let’s determine the extent of company efficiency that accounts for 322 employees. In terms of profitability, gross margin is 77.1%, operating margin of -20.12%, and the pretax margin is -20.01%.
Mirum Pharmaceuticals Inc (MIRM) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Mirum Pharmaceuticals Inc is 19.18%, while institutional ownership is 93.48%. The most recent insider transaction that took place on Jun 11 ’25, was worth 155,091. In this transaction Director of this company sold 3,203 shares at a rate of $48.42, taking the stock ownership to the 2,500 shares. Before that another transaction happened on Jun 11 ’25, when Company’s Director proposed sale 3,203 for $48.42, making the entire transaction worth $155,091.
Mirum Pharmaceuticals Inc (MIRM) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 39.83% per share during the next fiscal year.
Mirum Pharmaceuticals Inc (NASDAQ: MIRM) Trading Performance Indicators
Check out the current performance indicators for Mirum Pharmaceuticals Inc (MIRM). In the past quarter, the stock posted a quick ratio of 3.04. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 6.32.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.61, a number that is poised to hit -0.33 in the next quarter and is forecasted to reach -0.49 in one year’s time.
Technical Analysis of Mirum Pharmaceuticals Inc (MIRM)
Looking closely at Mirum Pharmaceuticals Inc (NASDAQ: MIRM), its last 5-days average volume was 0.52 million, which is a jump from its year-to-date volume of 0.48 million. As of the previous 9 days, the stock’s Stochastic %D was 51.33%.
During the past 100 days, Mirum Pharmaceuticals Inc’s (MIRM) raw stochastic average was set at 66.32%, which indicates a significant increase from 14.49% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 27.27% in the past 14 days, which was lower than the 39.74% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $45.56, while its 200-day Moving Average is $44.08. However, in the short run, Mirum Pharmaceuticals Inc’s stock first resistance to watch stands at $49.99. Second resistance stands at $51.59. The third major resistance level sits at $52.46. If the price goes on to break the first support level at $47.51, it is likely to go to the next support level at $46.64. Now, if the price goes above the second support level, the third support stands at $45.04.
Mirum Pharmaceuticals Inc (NASDAQ: MIRM) Key Stats
There are currently 49,535K shares outstanding in the company with a market cap of 2.40 billion. Presently, the company’s annual sales total 336,890 K according to its annual income of -87,940 K. Last quarter, the company’s sales amounted to 111,590 K and its income totaled -14,680 K.
